The same study also analyzed BRAF mutations in plasma cfDNA, and the results were similar in all three groups: 15% in those with CRC, 20% in individuals with neoplastic polyps, and 11% in healthy controls suggesting technical or biological issues. Here, BRAF is linked to colorectal carcinoma.